About us
Company
Leadership
Approach
Positioning
Platforms
Programs
Partnerships
Collaborations
Partners
News & Media
Press releases
News
Resources
Posters SITC 2022
Opportunities
Partnering Opportunities
Careers
Search on our website
Type Enter to start searching.
Pipeline
Press room
Press releases
Scroll to explore
Latest press releases
2023
2022
2021
2020
2019
2018
2017
2016
Scroll back top
6 February 2023
Domain Therapeutics to Participate in Upcoming Investor and Industry Conferences
Discover more
5 January 2023
Domain Therapeutics announces first patient dosed with DT-9081 in phase I clinical study in patients...
Discover more
8 December 2022
Domain Therapeutics strengthens Scientific Advisory Board with appointment of immuno-oncology expert...
Discover more
10 November 2022
Domain Therapeutics presents new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meeting
Discover more
19 October 2022
Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumor...
Discover more
6 October 2022
Domain Therapeutics to present new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meetin...
Discover more
28 June 2022
Domain Therapeutics receives a single digit multimillion development milestone payment from Merck fo...
Discover more
10 May 2022
Domain Therapeutics raises $42m Series A financing
Discover more
19 April 2022
Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GP...
Discover more
10 March 2022
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
Discover more
News & Media
News